mots c vs tirzepatide Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology is distinct: • (Manjaro): This is a dual agonist targeting GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic GLP1 peptides such as semaglutide
Description
Why tirzepatide and not just semaglutide
Extra caution is warranted given the higher cost and limited availability of retatrutide

Both medications stimulate the GLP-1 receptor, which increases intestinal water secretion and speeds colonic transit

However, some patients have successfully submitted receipts to their insurance company or HSA/FSA for partial reimbursement
